AU2016215453A1 - Nanopore detection of target polynucleotides from sample background - Google Patents
Nanopore detection of target polynucleotides from sample background Download PDFInfo
- Publication number
- AU2016215453A1 AU2016215453A1 AU2016215453A AU2016215453A AU2016215453A1 AU 2016215453 A1 AU2016215453 A1 AU 2016215453A1 AU 2016215453 A AU2016215453 A AU 2016215453A AU 2016215453 A AU2016215453 A AU 2016215453A AU 2016215453 A1 AU2016215453 A1 AU 2016215453A1
- Authority
- AU
- Australia
- Prior art keywords
- nanopore
- sample
- target polynucleotide
- amplification
- amplicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 274
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 274
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 274
- 238000001514 detection method Methods 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 155
- 230000003321 amplification Effects 0.000 claims abstract description 140
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 140
- 239000011148 porous material Substances 0.000 claims description 187
- 108091093088 Amplicon Proteins 0.000 claims description 151
- 239000000523 sample Substances 0.000 claims description 151
- 108020004414 DNA Proteins 0.000 claims description 123
- 102000053602 DNA Human genes 0.000 claims description 120
- 238000003752 polymerase chain reaction Methods 0.000 claims description 99
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 80
- 238000006243 chemical reaction Methods 0.000 claims description 75
- 238000010790 dilution Methods 0.000 claims description 52
- 239000012895 dilution Substances 0.000 claims description 52
- 229960002685 biotin Drugs 0.000 claims description 40
- 235000020958 biotin Nutrition 0.000 claims description 40
- 239000011616 biotin Substances 0.000 claims description 40
- 238000009739 binding Methods 0.000 claims description 32
- 230000027455 binding Effects 0.000 claims description 30
- 230000021615 conjugation Effects 0.000 claims description 30
- 229920002477 rna polymer Polymers 0.000 claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- 239000013068 control sample Substances 0.000 claims description 22
- 230000003993 interaction Effects 0.000 claims description 22
- 150000007523 nucleic acids Chemical class 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 21
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 20
- 238000011068 loading method Methods 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 238000006073 displacement reaction Methods 0.000 claims description 18
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 230000035945 sensitivity Effects 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 238000000746 purification Methods 0.000 claims description 10
- 230000005945 translocation Effects 0.000 claims description 10
- 230000001965 increasing effect Effects 0.000 claims description 9
- 230000001404 mediated effect Effects 0.000 claims description 9
- 230000001419 dependent effect Effects 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 7
- 108060004795 Methyltransferase Proteins 0.000 claims description 7
- 238000011901 isothermal amplification Methods 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 108091008102 DNA aptamers Proteins 0.000 claims description 6
- 239000000412 dendrimer Substances 0.000 claims description 6
- 229920000736 dendritic polymer Polymers 0.000 claims description 6
- 229910003472 fullerene Inorganic materials 0.000 claims description 6
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 238000007854 ligation-mediated PCR Methods 0.000 claims description 6
- 239000002502 liposome Substances 0.000 claims description 6
- 239000002073 nanorod Substances 0.000 claims description 6
- 239000002071 nanotube Substances 0.000 claims description 6
- 238000003757 reverse transcription PCR Methods 0.000 claims description 6
- 230000004931 aggregating effect Effects 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical group [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 150000001540 azides Chemical class 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000002102 nanobead Substances 0.000 claims description 4
- 238000007397 LAMP assay Methods 0.000 claims description 3
- 125000003636 chemical group Chemical group 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 238000013412 genome amplification Methods 0.000 claims description 2
- 230000010076 replication Effects 0.000 claims description 2
- 238000013207 serial dilution Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 9
- 108700032475 Sex-Determining Region Y Proteins 0.000 description 58
- 102100022978 Sex-determining region Y protein Human genes 0.000 description 58
- 239000012528 membrane Substances 0.000 description 31
- 101001088879 Homo sapiens Lysine-specific demethylase 5D Proteins 0.000 description 23
- 229920000642 polymer Polymers 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 19
- 102100033143 Lysine-specific demethylase 5D Human genes 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000000872 buffer Substances 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 101150059736 SRY gene Proteins 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 239000011543 agarose gel Substances 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 230000001745 anti-biotin effect Effects 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 108700019146 Transgenes Proteins 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 230000009149 molecular binding Effects 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 238000005411 Van der Waals force Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- -1 nucleotide triphosphates Chemical class 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 229910052581 Si3N4 Inorganic materials 0.000 description 3
- 210000002593 Y chromosome Anatomy 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- 235000011178 triphosphate Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010069755 K-ras gene mutation Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 238000010459 TALEN Methods 0.000 description 2
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 235000011147 magnesium chloride Nutrition 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000032693 46 XY Gonadal Dysgenesis Diseases 0.000 description 1
- 208000014019 46,XY complete gonadal dysgenesis Diseases 0.000 description 1
- 208000027215 46,XY sex reversal Diseases 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- ZUHQCDZJPTXVCU-UHFFFAOYSA-N C1#CCCC2=CC=CC=C2C2=CC=CC=C21 Chemical compound C1#CCCC2=CC=CC=C2C2=CC=CC=C21 ZUHQCDZJPTXVCU-UHFFFAOYSA-N 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000941423 Grom virus Species 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000013206 minimal dilution Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000000819 phase cycle Methods 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 238000012123 point-of-care testing Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 150000007944 thiolates Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/131—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/631—Detection means characterised by use of a special device being a biochannel or pore
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018208656A AU2018208656A1 (en) | 2015-02-02 | 2018-07-24 | Nanopore detection of target polynucleotides from sample background |
| AU2020239812A AU2020239812A1 (en) | 2015-02-02 | 2020-09-25 | Nanopore detection of target polynucleotides from sample background |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562111075P | 2015-02-02 | 2015-02-02 | |
| US62/111,075 | 2015-02-02 | ||
| PCT/US2016/016233 WO2016126746A1 (en) | 2015-02-02 | 2016-02-02 | Nanopore detection of target polynucleotides from sample background |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018208656A Division AU2018208656A1 (en) | 2015-02-02 | 2018-07-24 | Nanopore detection of target polynucleotides from sample background |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2016215453A1 true AU2016215453A1 (en) | 2017-08-10 |
Family
ID=56564617
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016215453A Abandoned AU2016215453A1 (en) | 2015-02-02 | 2016-02-02 | Nanopore detection of target polynucleotides from sample background |
| AU2018208656A Abandoned AU2018208656A1 (en) | 2015-02-02 | 2018-07-24 | Nanopore detection of target polynucleotides from sample background |
| AU2020239812A Abandoned AU2020239812A1 (en) | 2015-02-02 | 2020-09-25 | Nanopore detection of target polynucleotides from sample background |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018208656A Abandoned AU2018208656A1 (en) | 2015-02-02 | 2018-07-24 | Nanopore detection of target polynucleotides from sample background |
| AU2020239812A Abandoned AU2020239812A1 (en) | 2015-02-02 | 2020-09-25 | Nanopore detection of target polynucleotides from sample background |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11098348B2 (https=) |
| EP (1) | EP3253889A4 (https=) |
| JP (2) | JP2018505414A (https=) |
| KR (2) | KR20190127983A (https=) |
| CN (1) | CN107250380A (https=) |
| AU (3) | AU2016215453A1 (https=) |
| CA (1) | CA2973753A1 (https=) |
| HK (1) | HK1245348A1 (https=) |
| IL (1) | IL253272B (https=) |
| MX (1) | MX2017009766A (https=) |
| RU (1) | RU2017127990A (https=) |
| WO (1) | WO2016126746A1 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
| US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
| US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
| WO2014182634A1 (en) | 2013-05-06 | 2014-11-13 | Two Pore Guys, Inc. | A method of biological target detection using a nanopore and a fusion protein binding agent |
| KR102245192B1 (ko) | 2013-05-06 | 2021-04-29 | 온테라 인크. | 나노포어를 이용한 표적 검출 |
| EP3174502B1 (en) | 2014-07-30 | 2022-04-06 | Cardiovalve Ltd | Apparatus for implantation of an articulatable prosthetic valve |
| JP6702951B2 (ja) * | 2014-09-26 | 2020-06-03 | オンテラ インコーポレイテッド | 合成プローブのナノ細孔センシングによる標的配列検出 |
| EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
| JP2018537673A (ja) * | 2015-11-23 | 2018-12-20 | ツー ポア ガイズ インコーポレイテッド | 追跡及び検出のための標的修飾 |
| US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
| US10640822B2 (en) | 2016-02-29 | 2020-05-05 | Iridia, Inc. | Systems and methods for writing, reading, and controlling data stored in a polymer |
| US10438662B2 (en) | 2016-02-29 | 2019-10-08 | Iridia, Inc. | Methods, compositions, and devices for information storage |
| US10859562B2 (en) | 2016-02-29 | 2020-12-08 | Iridia, Inc. | Methods, compositions, and devices for information storage |
| US11486873B2 (en) | 2016-03-31 | 2022-11-01 | Ontera Inc. | Multipore determination of fractional abundance of polynucleotide sequences in a sample |
| US20190231525A1 (en) | 2016-08-01 | 2019-08-01 | Mitraltech Ltd. | Minimally-invasive delivery systems |
| ES3018641T3 (es) | 2016-08-10 | 2025-05-16 | Cardiovalve Ltd | Válvula protésica con marcos concéntricos |
| AU2017348009B2 (en) | 2016-10-24 | 2019-10-10 | Ontera Inc. | Fractional abundance of polynucleotide sequences in a sample |
| KR102076592B1 (ko) * | 2017-05-25 | 2020-02-13 | 가천대학교 산학협력단 | 나노기공 센서를 사용한 dna 농도 측정 장치 및 방법 |
| US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
| US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
| US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
| US12458493B2 (en) | 2017-09-19 | 2025-11-04 | Cardiovalve Ltd. | Prosthetic heart valve and delivery systems and methods |
| CN108181358B (zh) * | 2017-11-15 | 2020-02-11 | 华东理工大学 | 基于气单胞菌溶素纳米通道检测氨基酸的方法 |
| CN109239140B (zh) * | 2018-08-16 | 2021-04-13 | 广东第二师范学院 | 一种纳米孔功能性控制方法及系统 |
| CN113966403A (zh) * | 2019-04-22 | 2022-01-21 | 奥特拉公司 | 样品中多核苷酸序列的分数丰度的多孔测定 |
| US20200340943A1 (en) * | 2019-04-26 | 2020-10-29 | The University Of Ottawa | Calibrating Nanopore Capture Rates Using Controlled Counting |
| CN110438203B (zh) * | 2019-08-19 | 2023-11-28 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种提高环介导等温扩增反应效率的方法及应用 |
| JP7344786B2 (ja) * | 2019-12-19 | 2023-09-14 | 株式会社日立製作所 | 溶液中の任意のｄｎａ配列を同定する方法 |
| KR102358418B1 (ko) * | 2019-12-31 | 2022-02-04 | 주식회사 제노헬릭스 | 스몰 rna 검출 방법 |
| WO2021156370A1 (en) * | 2020-02-06 | 2021-08-12 | F. Hoffmann-La Roche Ag | Compositions that reduce template threading into a nanopore |
| US11837302B1 (en) | 2020-08-07 | 2023-12-05 | Iridia, Inc. | Systems and methods for writing and reading data stored in a polymer using nano-channels |
| US12357459B2 (en) | 2020-12-03 | 2025-07-15 | Cardiovalve Ltd. | Transluminal delivery system |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05273209A (ja) | 1992-03-25 | 1993-10-22 | Takara Shuzo Co Ltd | Ｄｎａ検出用キット |
| JPH11346798A (ja) | 1998-06-04 | 1999-12-21 | Makoto Tsuruoka | 核酸の測定方法およびＶｅｒｏ毒素生産菌の検出方法 |
| US20020197618A1 (en) | 2001-01-20 | 2002-12-26 | Sampson Jeffrey R. | Synthesis and amplification of unstructured nucleic acids for rapid sequencing |
| AU2002359510A1 (en) * | 2001-11-30 | 2003-06-17 | Nanosphere, Inc. | Real-time monitoring of pcr amplification using nanoparticle probes |
| US6952651B2 (en) | 2002-06-17 | 2005-10-04 | Intel Corporation | Methods and apparatus for nucleic acid sequencing by signal stretching and data integration |
| WO2004001379A2 (en) | 2002-06-20 | 2003-12-31 | The Regents Of The University Of California | Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| US7270956B2 (en) | 2002-08-26 | 2007-09-18 | The Regents Of The University Of California | Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| US20040022764A1 (en) | 2002-07-31 | 2004-02-05 | Hanan Polansky | Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease |
| DE602004030114D1 (de) | 2003-05-20 | 2010-12-30 | Investigen Inc | System zum nachweis von polynukleotiden |
| US20050186576A1 (en) | 2004-02-19 | 2005-08-25 | Intel Corporation | Polymer sequencing using selectively labeled monomers and data integration |
| TWI291416B (en) * | 2005-07-19 | 2007-12-21 | Benq Corp | Business equipment |
| KR100691806B1 (ko) * | 2005-08-04 | 2007-03-12 | 삼성전자주식회사 | 비드 및 나노포어를 이용한 핵산 검출방법 및 검출장치 |
| US20070048745A1 (en) | 2005-08-30 | 2007-03-01 | Joyce Timothy H | Systems and methods for partitioned nanopore analysis of polymers |
| US20070190543A1 (en) * | 2005-11-14 | 2007-08-16 | Applera Corporation | Coded Molecules for Detecting Target Analytes |
| WO2007117832A2 (en) * | 2006-03-12 | 2007-10-18 | Applera Corporation | Methods of detecting target nucleic acids |
| US8889348B2 (en) | 2006-06-07 | 2014-11-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by nanopore using modified nucleotides |
| AU2008236694B2 (en) | 2007-04-04 | 2014-01-23 | The Regents Of The University Of California | Compositions, devices, systems, and methods for using a nanopore |
| US20080268440A1 (en) * | 2007-04-26 | 2008-10-30 | Liu Timothy Z | Biomolecule immobilization on surface via hydrophobic interactions |
| GB0717150D0 (en) | 2007-09-04 | 2007-10-17 | Univ Warwick | Apparatus and method |
| US8329647B2 (en) * | 2008-07-17 | 2012-12-11 | Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh | Method of treating a subject according to biomarkers for insulin resistance |
| US8262879B2 (en) | 2008-09-03 | 2012-09-11 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
| AU2010301128B2 (en) | 2009-09-30 | 2014-09-18 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| KR101267789B1 (ko) | 2010-06-25 | 2013-06-04 | 서울대학교산학협력단 | 나노 포어 구조를 이용한 ｄｎａ 분석용 장치, 분석 방법 및 ｐｃｒ 정량 검출 장치 |
| WO2012088339A2 (en) | 2010-12-22 | 2012-06-28 | Genia Technologies, Inc. | Nanopore-based single dna molecule characterization using speed bumps |
| WO2012135658A2 (en) | 2011-03-30 | 2012-10-04 | Noblegen Biosciences, Inc. | Sequence preserved dna conversion for optical nanopore sequencing |
| US9926596B2 (en) * | 2011-05-27 | 2018-03-27 | Genapsys, Inc. | Systems and methods for genetic and biological analysis |
| EP2734840B3 (en) | 2011-07-20 | 2017-06-07 | The Regents of the University of California | Dual-pore device |
| AU2012288629B2 (en) | 2011-07-25 | 2017-02-02 | Oxford Nanopore Technologies Limited | Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores |
| US20130040827A1 (en) * | 2011-08-14 | 2013-02-14 | Stephen C. Macevicz | Method and compositions for detecting and sequencing nucleic acids |
| EP3674412A1 (en) * | 2012-06-20 | 2020-07-01 | The Trustees of Columbia University in the City of New York | Nucleic acid sequencing by nanopore detection of tag molecules |
| WO2014024041A1 (en) | 2012-08-06 | 2014-02-13 | Quantumdx Group Limited | Method and kit for nucleic acid sequencing |
| US20140099726A1 (en) | 2012-10-10 | 2014-04-10 | Two Pore Guys, Inc. | Device for characterizing polymers |
| US9732379B2 (en) | 2013-03-15 | 2017-08-15 | The Curators Of The University Of Missouri | Encoded nanopore sensor for multiplex nucleic acids detection |
| WO2014182634A1 (en) | 2013-05-06 | 2014-11-13 | Two Pore Guys, Inc. | A method of biological target detection using a nanopore and a fusion protein binding agent |
| US20150011925A1 (en) * | 2013-07-08 | 2015-01-08 | Robert F. Buckman, Jr. | Method and device for temporary emergency vessel anastomoses |
| CN107110817B (zh) * | 2014-12-31 | 2019-09-24 | 卡尤迪生物科技（北京）有限公司 | 使用纳米孔和标签的核酸分子检测 |
| CA2986921A1 (en) | 2015-06-02 | 2016-12-08 | Nanopore Diagnostics, Llc | Nucleic acid detection |
| WO2018093976A1 (en) | 2016-11-16 | 2018-05-24 | Nanopore Diagnostics, Llc | Analysis of nucleic acids using probe with non-linear tag |
-
2016
- 2016-02-02 EP EP16747143.2A patent/EP3253889A4/en not_active Withdrawn
- 2016-02-02 KR KR1020197032635A patent/KR20190127983A/ko not_active Withdrawn
- 2016-02-02 US US15/547,434 patent/US11098348B2/en active Active
- 2016-02-02 HK HK18104715.6A patent/HK1245348A1/zh unknown
- 2016-02-02 MX MX2017009766A patent/MX2017009766A/es unknown
- 2016-02-02 JP JP2017540801A patent/JP2018505414A/ja active Pending
- 2016-02-02 AU AU2016215453A patent/AU2016215453A1/en not_active Abandoned
- 2016-02-02 KR KR1020177024505A patent/KR20170106487A/ko not_active Ceased
- 2016-02-02 WO PCT/US2016/016233 patent/WO2016126746A1/en not_active Ceased
- 2016-02-02 CA CA2973753A patent/CA2973753A1/en not_active Abandoned
- 2016-02-02 RU RU2017127990A patent/RU2017127990A/ru unknown
- 2016-02-02 CN CN201680008155.7A patent/CN107250380A/zh active Pending
-
2017
- 2017-07-02 IL IL253272A patent/IL253272B/en active IP Right Grant
-
2018
- 2018-07-24 AU AU2018208656A patent/AU2018208656A1/en not_active Abandoned
- 2018-12-10 JP JP2018230605A patent/JP2019092509A/ja active Pending
-
2020
- 2020-09-25 AU AU2020239812A patent/AU2020239812A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016126746A1 (en) | 2016-08-11 |
| EP3253889A4 (en) | 2018-09-26 |
| JP2019092509A (ja) | 2019-06-20 |
| MX2017009766A (es) | 2017-12-11 |
| AU2020239812A1 (en) | 2020-10-29 |
| RU2017127990A3 (https=) | 2019-03-04 |
| US20180023115A1 (en) | 2018-01-25 |
| RU2017127990A (ru) | 2019-03-04 |
| KR20170106487A (ko) | 2017-09-20 |
| HK1245348A1 (zh) | 2018-08-24 |
| US11098348B2 (en) | 2021-08-24 |
| KR20190127983A (ko) | 2019-11-13 |
| CA2973753A1 (en) | 2016-08-11 |
| IL253272B (en) | 2018-08-30 |
| AU2018208656A1 (en) | 2018-08-09 |
| EP3253889A1 (en) | 2017-12-13 |
| IL253272A0 (en) | 2017-09-03 |
| CN107250380A (zh) | 2017-10-13 |
| JP2018505414A (ja) | 2018-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11098348B2 (en) | Nanopore detection of target polynucleotides from sample background | |
| US10837050B2 (en) | Methods for beaming | |
| US10871482B2 (en) | Target detection with nanopore and a polymer scaffold complex | |
| US8715933B2 (en) | Assay methods using nicking endonucleases | |
| JP7796858B2 (ja) | ナノ細孔デバイス内で特徴をマッピングするための強制移動ポリヌクレオチドスキャンニング | |
| JP2019516087A (ja) | 断片化及びペイロード結合による試料バックグラウンドからの標的ポリヌクレオチドのナノ細孔識別 | |
| Loh et al. | Electric single-molecule hybridization detector for short DNA fragments | |
| US20230194500A1 (en) | Ultrasensitive rna quantification using nanopores | |
| US20200024650A1 (en) | Target Polynucleotide Detection and Sequencing by Incorporation of Modified Nucleotides for Nanaopore Analysis | |
| King | Nanopore Sensing of PCR-Amplified Pathogenic DNA | |
| CN108026574A (zh) | 模板核酸的分析方法、靶物质的分析方法、模板核酸或靶物质的分析用试剂盒及模板核酸或靶物质的分析用装置 | |
| HK1121193B (en) | Improved methods for beaming |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |